The 'real world' utility of miRNA patents: Lessons learned from expressed sequence tags

Nature Biotechnology

Volumn 29, Issue 2, 2011, Pages 129-133

  McLeod, Bonnie W ^a   Hayman, Mark L ^a   Purcell, Angela L ^a   Marcus, Joshua S ^a   Veitenheimer, Erich ^a  

^a Cooley LLP ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; STEROID;

ARTICLE; GENE SEQUENCE; GENOMICS; LICENSING; PATENT; PRIORITY JOURNAL;

ANIMALS; BIOTECHNOLOGY; DISCLOSURE; DRUG INDUSTRY; EXPRESSED SEQUENCE TAGS; HUMANS; INTELLECTUAL PROPERTY; MICRORNAS; PATENTS AS TOPIC;

EID: 79751496102     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt.1765     Document Type: Article

References (56)

1. Fire, A. et al. Nature 391, 806-811 (1998).
2. He, L. & Hannon, G.J. Nat. Rev. Genet. 5, 522-531 (2004).
3. Townley-Tilson, W.H., Callis, T.E. & Wang, D. Int. J. Biochem. Cell Biol. 42, 1252-1255 (2010).
4. Zheng, K. et al. J. Neurosci. 30, 8245-8250 (2010).
5. Jones, C.I. & Newbury, S.F. Biochem. Soc. Trans. 38, 1137-1143 (2010).
6. Letzen, B.S. et al. PLoS ONE 5, e10480 (2010).
7. Almanza, G. et al. PLoS ONE 5, e11243 (2010).
8. Yu, Z. et al. Am. J. Pathol. 176, 1058-1064 (2010).
9. Cho, W.C. Biochim. Biophys. Acta 1805, 209-217 (2010).
10. Hime, G.R. & Somers, W.G. Cell Adh. Migr. 3, 425-432 (2009).
11. Weber, M., Baker, M.B., Moore, J.P. & Searles, C.D. Biochem. Biophys. Res. Commun. 393, 643-648 (2010).
12. Elia, L. et al. Cell Death Differ. 16, 1590-1598 (2009).
13. Huang, Z.P., Neppl, R.L. & Wang, D.Z. J. Cardiovasc. Transl. Res. 3, 212-218 (2010).
14. Adams, B.D., Furneaux, H. & White, B.A. Mol. Endocrinol. 21, 1132-1147 (2007).
15. Sullivan, C.S. & Ganem, D. Mol. Cell 20, 3-7 (2005).
16. Lecellier, C.-H. et al. Science 308, 557-560 (2005).
17. Taganov, K.D., Boldin, M.P., Chang, K.-J. & Baltimore, D. Proc. Natl. Acad. Sci. USA 103, 12481-12486 (2006).
18. Taganov, K.D., Boldin, M.P. & Baltimore, D. Immunity 26, 133-137 (2007).
19. Davis, P., Kelley, J.J., Caltrider, S.P. & Heinig, S.J. Nat. Biotechnol. 23, 1227-1229 (2005).
20. US 11/747,409, Office Action dated February 13, 2009.
21. US 11/747,409, Reply to Office Action dated August 3, 2009; Cf. In re Fisher, 421 F.3d 1365, 1376 (Fed. Cir. 2005).
22. EP 02782801, Examiner's Report dated July 28, 2009.
23. Ibid..
24. http://www.alnylam.com/Business-Development/Academic-Federal-and- Foundation-Collaborations. php.
25. 23, 2010 (claims directed to miRNA-142 sequences); 12/550,596, issued as US Patent No. 7,838,662 on November 23, 2010 (claims directed to miRNA-15a, 15b and 16 sequences); 12/550,579, issued as US Patent No. 7,838,660 on November 23, 2010 (claims directed to miRNA155 sequences).
26. USC §101.
27. Manual of Patent Examining Procedure §2107; "Utility Examination Guidelines," Fed. Regist. 66, 1092-1099 (2001).
28. Manual of Patent Examining Procedure §2107.01; see also Fisher, 421 F.3d at 1376 (Fed. Cir. 2005).
29. Manual of Patent Examining Procedure §2107.01.
30. Davis, et al. at n. 19; see also Overview of Comments in "Utility Examination Guidelines". Fed. Regist. 66, 1092-1099 (2001).
31. Reynolds, T. J. Natl. Cancer Inst. 92, 96-97 (2000).
32. Manual of Patent Examining Procedure §2107.01(I) (A).
33. In re: Kirk 376 F.2d 936 (CCPA 1967).
34. Reynolds at n. 30.
35. Manual of Patent Examining Procedure §2107.01(I) (B).
36. Nelson v. Bowler, 626 F.2d 853 (CCPA 1980).
37. MPEP at n. 34.
38. Manual of Patent Examining Procedure §2107.02(III) (B).
39. Ibid..
40. Rasmusson v. SmithKline Beecham Corp., 75 USPQ 1297, 1300 (Fed. Cir. 2005), quoting Envirotech
41. Corp. v. Al George, Inc., 221 USPQ 473 (Fed. Cir. 1984).
42. Rasmusson, at 1300.
43. F.3d 1365 (Fed. Cir. 2005).
44. d. at 1374.
45. Ibid..
46. F.3d 1376.
47. th Advanced Forum on Biotech Patents (Sept. 2005). http://www. wsgr.com/attorneys/NEWBIOS/PDFs/storella0905. pdf
48. Schultz, J.D. Patenting Interfering RNA, SPE Art Unit 1635, USPTO (date unknown). http://www.cabic. com/bcp/061307/JSchultz-PIRNA.ppt
49. Smalheiser, N.R. & Torvil, V.I. in MicroRNA Protocols (ed. Ying, S.-Y.) 115-127 (Humana Press, 2006).
50. Rasmusson at n. 40.
51. Maragkakis, M. et al. BMC Bioinformatics 10, 295-304 (2009).
52. Kunin, S.G., Nagumo, M., Stanton, B., Therkorn, L.S. & Walsh, S. Am. Univ. Law Rev. 51, 609-638 (2002).
53. USC §112 (2001).
54. Kunin et al. at n. 50.
55. Vas-Cath Inc. v. Mahurkar, 935 F.2d 1555, 1563-64 (Fed. Cir. 1991).
56. US 10/909,125, Notice of Allowability dated October 22, 2009.